FDA approves Tanzeum (albiglutide) to treat type 2 diabetes
FDA NEWS RELEASE: April 15, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm393289.htm
Leggi
European public assessment report for Vokanamet (canagliflozin / metformin)
EMA, 15/5/2014 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002656/human_med_001760.jsp&mid=WC0b01ac058001d124
Leggi
Combined use of medicines affecting the renin-angiotensin system (RAS) to be restricted – CHMP endorses PRAC recommendation
EMA, 23 maggio 2014 http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/05/news_detail_002107.jsp&mid=WC0b01ac058004d5c1 http://www.agenziafarmaco.gov.it/sites/default/files/RAS_agents_public_health_communication_IT%20.pdf
Leggi
FDA Drug Safety Communication: FDA review of cardiovascular risks for diabetics taking hypertension drug olmesartan not conclusive; label updates required (6-24-2014)
http://www.fda.gov/drugs/drugsafety/ucm402323.htm http://www.fda.gov/downloads/Drugs/DrugSafety/UCM402339.pdf
Leggi
FDA approves Afrezza (insulin human) Inhalation Powder to treat diabetes
FDA News Release, June 27, 2014 http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm403122.htm
Leggi
L’uso dei farmaci in Italia – Rapporto OsMed 2013
http://www.agenziafarmaco.gov.it/it/content/luso-dei-farmaci-italia-rapporto-osmed-2013
Leggi
Confidentiality of Interim Results in Cardiovascular Outcome Safety Trials; Public Hearing; Request for Comments
A Proposed Rule by the Food and Drug Administration on 07/15/2014 https://s3.amazonaws.com/public-inspection.federalregister.gov/2014-16374.pdf
Leggi
Xultophy
European Medicines Agency, 25/07/2014 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002647/smops/Positive/human_smop_000714.jsp&mid=WC0b01ac058001d127
Leggi
CHMP summary of positive opinion for Xultophy
http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002647/WC500170171.pdf
Leggi
FDA NEWS RELEASE
Jan. 8, 2014 FDA approves Farxiga (dapaglifozin) to treat type 2 diabetes http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm380829.htm
Leggi